Undalig, Arnel .
HRN: 26-79-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/27/2025
04/09/2025
IV
500 Mg
Q 6 Hours
Tetatus
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes